|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Feb. 15, 2019 |
$$268.98 |
Feb. 23, 2019 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Feb. 15, 2019 |
$$1,001 - $15,000 |
Feb. 23, 2019 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 30, 2018 |
$$1,001 - $15,000 |
Dec. 11, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 30, 2018 |
$$909.75 |
Dec. 30, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 30, 2018 |
$$363.90 |
Dec. 9, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 30, 2018 |
$$1,001 - $15,000 |
Dec. 9, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 29, 2018 |
$$816.61 |
Dec. 9, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 29, 2018 |
$$1,001 - $15,000 |
Dec. 11, 2018 |
|
Alan S. Lowenthal
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
Nov. 29, 2018 |
$$15,001 - $50,000 |
Dec. 9, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG SPONSORED ADR (SWITZERLAND) |
NVS |
STOCK |
PURCHASE
|
Nov. 21, 2018 |
$$1,001 - $15,000 |
Dec. 7, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG S PONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Purchase
|
Sept. 23, 2018 |
$$1,000,001 - $5,000,000 |
Oct. 9, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG S PONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Purchase
|
Sept. 19, 2018 |
$$100,001 - $250,000 |
Oct. 9, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG S PONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Sale
|
Sept. 19, 2018 |
$$250,001 - $500,000 |
Oct. 9, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG S PONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
Exchange
|
Sept. 19, 2018 |
$$500,001 - $1,000,000 |
Oct. 9, 2018 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale (partial)
|
May 11, 2018 |
$$1,001 - $15,000 |
June 5, 2018 |
|
Lois Frankel
|
house |
NuVasive, Inc. (NuVA) |
NVSI |
STOCK |
Purchase
|
May 3, 2018 |
$$1,001 - $15,000 |
May 29, 2018 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
April 25, 2018 |
$$1,001 - $15,000 |
May 10, 2018 |
|
Lois Frankel
|
house |
NuVasive, Inc. (NuVA) |
NVSI |
STOCK |
Purchase
|
April 4, 2018 |
$$1,001 - $15,000 |
April 27, 2018 |
|
Francis Rooney
|
house |
Brown Advisory - Novartis AG Sponsored ADR (NVS) |
NVS |
STOCK |
Purchase
|
Dec. 29, 2017 |
$$1,000-$15,000 |
Jan. 10, 2018 |
|
James B. Renacci
|
house |
NOVARTIS AG S PONSORED ADR (SWITZERLAND) (NVS) |
NVS |
STOCK |
PURCHASE
|
Nov. 27, 2017 |
$$1,000 - $15,000 |
Dec. 6, 2017 |
|
Francis Rooney
|
house |
Brown Advisory - Novartis AG Sponsored ADR |
NVS |
STOCK |
Purchase
|
Sept. 13, 2017 |
$$1,000-$15,000 |
Sept. 18, 2017 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale
|
July 28, 2017 |
$$50,001 - $100,000 |
Aug. 3, 2017 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Sale
|
July 28, 2017 |
$$1,001 - $15,000 |
Aug. 3, 2017 |
|
John Rutherford
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
July 11, 2017 |
$$1,001 - $15,000 |
Aug. 20, 2018 |
|
Thomas MacArthur
|
house |
Novartis Ag (NVS) |
NVS |
STOCK |
Purchase
|
April 21, 2017 |
$$1,001 - $15,000 |
May 5, 2017 |